Safety and Effectiveness of NXY-059 for the Treatment of Patients Who Have Suffered From a Stroke

Clinical trial NCT00119626 · COMPLETED

Trial details

NCT number: NCT00119626
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Cerebral Stroke Ischemic Attack, Transient

Start date: 2003-06-01
Primary completion: 2005-02-01
Enrollment: 1700

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.